October 2019 CHR VOICE Digest

This issue of the VOICE once again has a lead article about the testing of embryos for chromosomal abnormalities (PGS/PGT-A). We can’t blame readers of the VOICE who are getting tired of the subject, but knowledge is changing quickly and, considering how many people get hurt daily around the world through utilization of PGS/PGT-A, we consider this one of the quintessential subjects in our specialty that must be covered whenever new data are published. A very important new paper was, indeed, just published electronically and, therefore, caused us to change our plans for this issue in the last moment. To those of you who are exhausted with the subject, we apologize; for those among our readers who are still unsure about PGS/PGT-A, they may find further clarification on the subject in this issue of the VOICE. And every normal human embryo with pregnancy chance that we can save from being mistakenly discarded, is more than worth the effort!

In this month’s CHR VOICE, we cover:

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.